See all request types:

General donations

Funding to organizations or institutions whose objectives include the support and revitalization of the local communities in which Biogen has a strong presence, or that support charitable causes and events of importance to Biogen, or that conduct patient outreach programs aligned to Biogen’s therapeutic areas of focus or its mission. Biogen also provides funding in support of socially responsible causes or in response to societal events.

  • Areas of Interest

    Biogen considers requests across a variety of disease and focus areas, including, but not limited to: Alzheimer’s Disease, Amyotrophic Lateral Sclerosis, Biosimilars, Chemistry, Drug Development, Fibrosis, Inflammatory Bowel Disease, Lupus, Lymphoma, Multiple Sclerosis, Myotonic Dystrophy, Neuropathic Pain, Ophthalmology, Parkinson’s Disease, Pharmacology, Sjogren’s Syndrome, Spinal Muscular Atrophy, Stroke, Trigeminal Neuralgia, and other Neurological disease areas.

    Biogen also considers requests from organizations whose objectives include the support and revitalization of the local communities in which Biogen has a strong presence or that support charitable causes and events of importance to Biogen or that align with its mission. 

  • How to Apply

    All requests will be reviewed on a quarterly basis after the open submission period completes its quarterly cycle. Funding requests should be submitted during the open submission period for the quarter prior to when a funding decision is needed by the organization. Biogen reserves the right to decline any applications not adhering to the deadline.

    See dates below highlighting the quarterly submission periods and their perspective dates the decisions will be communicated.

    Submission cycle Decisions communicated by:
    January 15 - February 15 March 30
    April 15 - May 15 June 30
    July 15 - August 15 September 30
    October 1 - November 1 December 15
  • Funding Requirements

    Donations may only be provided to qualified not-for-profit organizations and must be recognized by the IRS as a tax exempt, public charity under sections 501(c)(3) and 501(c)(6) of the internal revenue code and be located in the United States (or have W8-BEN status if not located in the United States); or be a US governmental organization (such as public schools, public colleges and universities, public hospitals and federally recognized Indian tribal governments).

    Donations must not provide nor promise to Biogen any tangible benefit.

    Additionally, all prior requests from the organization approved by Biogen must be appropriately reconciled before any new applications from the organization will be considered for funding.

    Biogen will conduct appropriate due diligence on applicants and applications and reserves the right to deny any request that does not meet its requirements.

  • Funding Restrictions & Limitations

    To avoid the appearance of lack of independence of our applicants, Biogen will review an organization's annual operating expenses against the level of individual and aggregate funding Biogen provided to the organization on a rolling twelve (12) month basis. 

  • Review Process and Decision

    Funding decisions for Grants and Donations are made through a formal, centralized grant review and decision-making process. Grant & Donation Review Committees assess and approve applications based upon need, design, scientific rigor, independence and compliance, as well as the potential to improve patient care and outcomes. Approvals depend on available funding, the volume of requests, and alignment with Biogen's mission and interest areas.  The Grant and Donation Review Committee may request additional detail or clarification of the activity's description or proposed budget, or other items, prior to the final funding decision.

    In all cases, Biogen notifies applicants of our decision by email.  Notification of decision shall only be communicated by the Grants Management & Strategic Giving office and no other Biogen staff member is authorized to approve or decline requests.  We receive many qualified and deserving applications and regret that we cannot fund all of them. All applications receive a fair review, and we encourage organizations to reapply for future programs.

  • Contracting

    All recipient organizations must abide by the terms and conditions as outlined in the Biogen Letter of Agreement (LOA), which is issued electronically to an authorized signatory of your organization once the application is approved. The organization must agree to the terms of the LOA before any payment is processed.

  • Program Execution

    If the scope of an approved program or activity changes, organizations must submit such changes via the Biogen Grants & Giving Portal in advance of such changes. Biogen will review the scope changes and assess whether funding for the activity should continue.

  • Reconciliation

    Recipient organizations must confirm receipt of funds and attest that funds were used for the purposes described in the contract. The approved use of funding must be reconciled, or assessed against the actual use of that funding, and reconciliation must be documented. 

    Failure of organizations to appropriately reconcile by the due date may delay further funding or cause denial of further applications.

Submit your proposal